GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cheng Du Sheng Nuo Biotec Co Ltd (SHSE:688117) » Definitions » Debt-to-Equity

Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Debt-to-Equity : 0.32 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cheng Du Sheng Nuo Biotec Co Debt-to-Equity?

Cheng Du Sheng Nuo Biotec Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥136.0 Mil. Cheng Du Sheng Nuo Biotec Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥151.4 Mil. Cheng Du Sheng Nuo Biotec Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥896.4 Mil. Cheng Du Sheng Nuo Biotec Co's debt to equity for the quarter that ended in Mar. 2024 was 0.32.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity or its related term are showing as below:

SHSE:688117' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04   Med: 0.15   Max: 0.32
Current: 0.32

During the past 7 years, the highest Debt-to-Equity Ratio of Cheng Du Sheng Nuo Biotec Co was 0.32. The lowest was 0.04. And the median was 0.15.

SHSE:688117's Debt-to-Equity is ranked worse than
52.38% of 842 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs SHSE:688117: 0.32

Cheng Du Sheng Nuo Biotec Co Debt-to-Equity Historical Data

The historical data trend for Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cheng Du Sheng Nuo Biotec Co Debt-to-Equity Chart

Cheng Du Sheng Nuo Biotec Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial - - 0.04 0.12 0.30

Cheng Du Sheng Nuo Biotec Co Quarterly Data
Dec18 Mar19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.31 0.32 0.30 0.32

Competitive Comparison of Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity falls into.



Cheng Du Sheng Nuo Biotec Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cheng Du Sheng Nuo Biotec Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Cheng Du Sheng Nuo Biotec Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cheng Du Sheng Nuo Biotec Co  (SHSE:688117) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Cheng Du Sheng Nuo Biotec Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cheng Du Sheng Nuo Biotec Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Industrial Avenue, Jinyuan Town, Dayi County, Sichuan Province, Chengdu, CHN, 611330
Cheng Du Sheng Nuo Biotec Co Ltd is a independent research and development, production and sales of peptide raw materials and preparation products.
Executives
Wang Xiao Li Directors, senior managers
Lu Chang Liang senior management
Zhang Hong Yan Directors, senior managers

Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Headlines

No Headlines